nancy and with hyperparathyroidism // J. Bone Miner. Res. — 1989. — V. 4 (Suppl.). —
P. 323.
Hendrickson F.R., Shehata W.M., Kirchner A.B.
Radiation therapy of osseous metas
tasis // Int. J. Radiol. Oncol. Biol. Phys. — 1976. — V. 1. — P. 275 278.
Hendson I.C., Allegra J.C., Woodcock T., Wolff T., Bryan S., Cartwright K., Ducart
G., Henry D.
Randomized clinical trial comparing mitoxantrone with doxorubicin in pre
viously treated patient with metastatic breast cancer // J. Clin. Onvcol. — 1989. — V. 7. —
P.568 571.
Hill J.M., Lobe E., Spesr R..J.
Colloidal phosphate P32. Clinical studies of over 250
cases // J. Nucl. Med. — 1962. — V. 3. — P.16.
Hinton J.
Dying. // Penguin Books. —Harmondsworth, Middx. — 1972. — P. 79 93.
Hoegler D.
Radiotherapy for palliation of symptoms in incurable cancer // Curr.
Probl. Cancer. — 1997. — V. 21(3). — P. 129 183.
Hoerster W., Kreuscher H., Niesel H.Chr., Zenz M.
Regional Anesthesia // Second
Edition.: Mosby Year Book. — 1990. — 229 p.
Hoffman H.L., Marly R..
Bone scaninf its value in the preoperative evalution of
patients with suspition breast masses // Am. J. Surg. — 1972. — V. 124. — P.194 199.
Hoffmann R.., Melcher I., Wichelhaus A., Haas N.P.
Surgical treatment of bone
metastases in breast cancer // Anticancer Res. — 1998. — V. 18(3C). — P. 2243 2249.
Holick M.F., Krane S.M., Potts J.T.
Calcium, phosphorus and bone metabolism: cal
cium regulating hormones // In: Harrison
,
s Principles of internal medicine. 12th ed. Ed.
J. Wison è ñîàâò. — 1991. — P. 1888 1902.
Holland B.R., Freyschmidt J.
MRI diagnosis of bone tumors // Orthopade. — 1994. —
V. 23(5). — P:355 365.
Hoogstraten B.
Adriamycin (NSC 123127) in the treatment of advanced breast can
cer: studies by the Southwest Oncology Group // Cancer Chem. Rep. — 1980. — Part 3,
6. —¹ 2. P. 329 496.
Horiuchi H., Caulfield M.P., Fisher J.E.
è ñîàâò. A similarity of synthetic peptide
from human tumor to parathyroid hormone in vitro and in vivo // Science. — 1987. —
V. 238. — P. 1566 1568.
Hortobagyi G.N., Libshitz H.I., Seabold J.E
. Osseos metastases of breast cancer.
Clinical, biochemical, radiografic and scintigraphic evalution of response to therapy //
Cancer 1984. — V. 55. — P. 577 582.
Hortobagyi G.N., Buzdar A.U., Frye D.
è ñîàâò. Oral medroxyprogesteron acetate in
the treatment of metasyatic breast cancer // Breast cancer Res. Treat. — 1985. — V. 5. —
P. 321 326.
Hortobahyi G.N., Frifsche H.A.
Carcinoembrionic antigen in brest cancer // Cancer
Bull. — 1985. — V. 37. —¹ 2. — P. 58 60.
Hortobahyi G.N., Fry D., Buzdar A.U., Ewer M.S., Franchini G., Hug V., Ames F.,
Montague E., Carrasco C.H., Maskay B., Benjamin R.S.
Decreased cardiac toxicity of dox
orubicin administeres by continuous intravenouos infusion in combination chemotherapy
for metastatic breast carcinoma // Cancer. — 1989. — V. 63. —¹ 1. — P. 37 45.
Hortobagyi G.N.
Multidisciplinary management of advanced primary and metastat
ic breast cancer // [Pap.] Amer. Cancer Soc. Nat. Breast Cancer, Boston, Mass., Aug.
26 28, 1993. — Cancer. — 1994. — V.1. — P. 416 423.
Hortobagyi G.N., Theriault R.L., Porter L.
è ñîàâò. Effycacy of pamidronate in
reducing skeletal complications in patients with breast cancer and lytic bone metastases //
The N. Engl. J. Med. — 1996. — V. 335. — P. 1785 1791.
230
Êîñòíûå ìåòàñòàçû ðàêà ìîëî÷íîé æåëåçû
